German Pharma Stock News

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...

Why Deutsche Telekom’s latest quarter is drawing fresh attention Deutsche Telekom (XTRA:DTE) is in focus after first quarter 2026 results exceeded analyst expectations, with strong EBITDA and service revenues from T Mobile US prompting the company to raise its annual profit forecast. Alongside the upgraded outlook, management reiterated priorities around artificial intelligence and continued fiber build out in Germany, positioning these areas as key themes investors may track through the rest...

Allianz (XTRA:ALV) just posted record first quarter 2026 operating profit of €4.5b, supported by Property Casualty and Asset Management, alongside a sharp rise in net income and an active share buyback program. See our latest analysis for Allianz. The record first quarter comes after a mixed period for the stock, with the share price down 3.97% year to date but supported by a 10.65% 1 year total shareholder return, suggesting long term momentum remains constructive despite recent...

BASF has commissioned a new fermentation plant at its BioHub facility for biological crop protection products. The company is highlighting its role in the Super Absorbent Polymer market, with a focus on sustainability driven applications. BASF is expanding its Safety Scouts farm safety education program as part of wider community engagement efforts. BASF (XTRA:BAS) is drawing attention for operational moves that sit outside headline earnings, from commissioning its BioHub fermentation plant...

thyssenkrupp (XTRA:TKA) has drawn investor attention after its latest reported figures highlighted annual revenue of €31,993.0 million and net income of €9.0 million. This has prompted a closer look at how the stock has been trading recently. See our latest analysis for thyssenkrupp. At a latest share price of €10.41, thyssenkrupp’s 1 day share price return of 5.15% and 30 day share price return of 24.05% suggest momentum has picked up recently. The 1 year total shareholder return of 48.91%...

The European market has recently seen modest gains, with the pan-European STOXX Europe 600 Index benefiting from easing geopolitical tensions and robust corporate earnings, although concerns about potential U.S. tariffs have tempered investor enthusiasm. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Why Deutsche Bank’s latest bond activity has caught investors’ attention Deutsche Bank (XTRA:DBK) has been active in May 2026, issuing and completing multiple fixed income offerings, including new senior unsecured notes with maturities stretching out to 2046 and a range of fixed coupons. This funding activity gives you a fresh data point on how the bank is raising long term capital, what kind of coupons it is willing to pay, and how its balance sheet mix between debt and equity might evolve...

Earnings context and what just changed AUTO1 Group (XTRA:AG1) has drawn investor attention after reporting first quarter 2026 results, with sales of €2,437.14 million and net income of €26.15 million, alongside record units sold and gross profit. See our latest analysis for AUTO1 Group. The first quarter update arrived alongside a sharp swing in sentiment, with a 1-day share price return of 12.90% and a 7-day share price return of 11.37%, even though the year to date share price return is...

PUMA (XTRA:PUM) is back in focus after appointing Mark Langer as Chief Financial Officer alongside releasing first quarter 2026 results. This combination gives investors fresh information on both leadership and earnings. See our latest analysis for PUMA. The recent CFO appointment and first quarter 2026 results come against a backdrop of improving share price momentum, with a 1 day share price return of 4.80%, a 90 day share price return of 11.63% and a 1 year total shareholder return of...

Why Hensoldt’s latest earnings matter for shareholders Hensoldt (XTRA:HAG) reported first quarter 2026 earnings with sales of €496 million, compared with €395 million a year earlier. The net loss improved to €19 million and basic loss per share to €0.16. See our latest analysis for Hensoldt. The first quarter update appears to have shifted sentiment in the short term, with a 1-day share price return of 3.95% to €74.3, even though the 90-day share price return is down 6.01% and the 5-year...

Adidas (XTRA:ADS) is back in the World Cup spotlight, unveiling its “Backyard Legends” campaign that digitally de ages Zidane, Beckham and Del Piero alongside Timothée Chalamet, Bad Bunny and Lionel Messi. See our latest analysis for adidas. The new World Cup campaign lands at a time when the stock’s 30 day share price return of 5.88% contrasts with a year to date decline of 13.98%. The 1 year total shareholder return is down 33.85%, pointing to near term momentum after a tougher longer term...

It's been a good week for Aurubis AG ( ETR:NDA ) shareholders, because the company has just released its latest...

Fresenius Medical Care AG's ( ETR:FME ) recent earnings report didn't offer any surprises, with the shares unchanged...

HORNBACH Holding AG & Co. KGaA ( ETR:HBH ), is not the largest company out there, but it saw significant share price...

What Hapag-Lloyd’s latest quarterly loss means for shareholders Hapag-Lloyd (XTRA:HLAG) just posted first quarter 2026 earnings that showed sales of €4,200.9m and a shift from prior year profit to a net loss of €220.3m, putting the stock firmly back in focus. See our latest analysis for Hapag-Lloyd. At a share price of €117.6, Hapag-Lloyd’s recent earnings loss and the approved merger agreement with ZIM have come against a backdrop of fairly muted share price moves over shorter periods and a...

SUSS MicroTec SE has reported past first-quarter 2026 results showing sales of €86.54 million versus €124.92 million a year earlier, with net income falling to €2.46 million from €16.6 million and basic earnings per share from continuing operations easing to €0.13 from €0.87. This sharp contraction in both revenue and profitability raises questions about how temporary current pressures are and how they interact with earlier expectations for stable margins and recurring revenue. Next, we’ll...

Lufthansa plans to exercise its option to acquire an additional 49% of ITA Airways, lifting its stake to 90%. The deal is structured as a capital injection into ITA and is intended to support a larger integration of the Italian carrier into the Lufthansa Group. The transaction is subject to regulatory approvals and is described as potentially accretive to Lufthansa’s earnings once completed. For investors watching XTRA:LHA, this move comes at a time when the stock trades around €8.13, with...

Eckert & Ziegler (XTRA:EUZ) opened Q1 2026 with revenue of €72.9 million and basic EPS of €0.17, as the stock trades around €14.80. This has put fresh attention on how the quarterly print lines up with the recent run of growth. Over the past year, revenue on a trailing 12 month basis has moved from €295.9 million to €316.7 million, while basic EPS has gone from €0.64 to €0.79. This sets the scene for investors to focus on how the higher net profit margins feed into the quality of the overall...

Bayer (XTRA:BAYN) has opened Q1 2026 with total revenue of €13.4 billion and basic EPS of €2.81, marking a sharp contrast with the loss it reported just a few quarters ago. Over the recent quarters, revenue has moved from €11.4 billion in Q4 2025 and €9.7 billion in Q3 2025 to the latest €13.4 billion, while basic EPS has shifted from a loss of €3.82 in Q4 2025 and a loss of €0.98 in Q3 2025 to a profit of €2.81. This sets up a quarter where margins are firmly back in focus and where the...

If you are wondering whether Siemens at €267.00 is still offering value or already pricing in a lot of optimism, you are not alone. The stock is roughly flat over the last 7 days, but it is up 16.7% over 30 days, 10.7% year to date and 21.7% over 1 year, with longer term returns of 87.1% over 3 years and 127.2% over 5 years. These moves sit against a backdrop where Siemens continues to attract attention in key industrial and infrastructure areas, drawing investors who are watching how large...

Siemens Energy Q2 2026: Earnings Hold Up As Profitability Beds In Siemens Energy (XTRA:ENR) heads into its Q2 2026 earnings discussion with Q1 2026 revenue of €9.7b, basic EPS of €0.79 and net income of €677m setting the tone for the current financial year. Over the past reported periods, revenue has ranged from €8.9b in Q1 2025 to €10.4b in Q4 2025, while basic EPS moved between €0.19 and €0.79 as the business shifted from a loss of €293m in Q4 2024 to consistent profit. With trailing 12...

Carl Zeiss Meditec (XTRA:AFX) reported weaker second quarter and first half 2025/2026 results, with lower sales and net income, and introduced its multi year Profit Up restructuring program targeting more than €200 million in annual profit improvements. See our latest analysis for Carl Zeiss Meditec. Despite the weak first half, the share price has reacted sharply in the short term, with a 1 day share price return of 12.36% and a 30 day share price return of 10.72%, while the 1 year total...